239 related articles for article (PubMed ID: 28543073)
1. Rapid response to intravenous vitamin K may obviate the need to transfuse prothrombin complex concentrates.
Sahai T; Tavares MF; Sweeney JD
Transfusion; 2017 Aug; 57(8):1885-1890. PubMed ID: 28543073
[TBL] [Abstract][Full Text] [Related]
2. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
3. Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication.
Yasaka M; Sakata T; Minematsu K; Naritomi H
Thromb Res; 2002 Oct; 108(1):25-30. PubMed ID: 12586128
[TBL] [Abstract][Full Text] [Related]
4. Protocolized use of Factor Eight Inhibitor Bypassing Activity (FEIBA) for the reversal of warfarin induced coagulopathy.
Htet NN; Barounis D; Knight C; Umunna BP; Hormese M; Lovell E
Am J Emerg Med; 2020 Mar; 38(3):539-544. PubMed ID: 31176578
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
6. Four-factor prothrombin complex concentrate for life-threatening bleeds or emergent surgery: A retrospective evaluation.
Sin JH; Berger K; Lesch CA
J Crit Care; 2016 Dec; 36():166-172. PubMed ID: 27546767
[TBL] [Abstract][Full Text] [Related]
7. Prospective Evaluation of a Fixed-Dose 4-Factor Prothrombin Complex Concentrate Protocol for Urgent Vitamin K Antagonist Reversal.
Bitonti MT; Rumbarger RL; Absher RK; Curran LM
J Emerg Med; 2020 Feb; 58(2):324-329. PubMed ID: 31787372
[TBL] [Abstract][Full Text] [Related]
8. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
[TBL] [Abstract][Full Text] [Related]
9. Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy.
Toth P; van Veen JJ; Robinson K; Maclean RM; Hampton KK; Laidlaw S; Makris M
Blood Transfus; 2013 Oct; 11(4):500-5. PubMed ID: 23114527
[TBL] [Abstract][Full Text] [Related]
10. Propensity score adjusted comparison of three-factor versus four-factor prothrombin complex concentrate for emergent warfarin reversal: a retrospective cohort study.
Margraf DJ; Seaburg S; Beilman GJ; Wolfson J; Gipson JC; Chapman SA
BMC Emerg Med; 2020 Nov; 20(1):93. PubMed ID: 33243152
[TBL] [Abstract][Full Text] [Related]
11. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
Stewart WS; Pettit H
Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
[TBL] [Abstract][Full Text] [Related]
12. Emergent reversal of vitamin K antagonists: addressing all the factors.
Martin DT; Barton CA; Dodgion C; Schreiber M
Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
[TBL] [Abstract][Full Text] [Related]
13. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K dosing to reverse warfarin based on INR, route of administration, and home warfarin dose in the acute/critical care setting.
Tsu LV; Dienes JE; Dager WE
Ann Pharmacother; 2012 Dec; 46(12):1617-26. PubMed ID: 23249867
[TBL] [Abstract][Full Text] [Related]
15. Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage.
Rowe AS; Mahbubani PS; Bucklin MH; Clark CT; Hamilton LA
Pharmacotherapy; 2016 Nov; 36(11):1132-1137. PubMed ID: 27726162
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study.
Kushimoto S; Fukuoka T; Kimura A; Toyoda K; Brainsky A; Harman A; Chung T; Yasaka M
Int J Hematol; 2017 Dec; 106(6):777-786. PubMed ID: 28815410
[TBL] [Abstract][Full Text] [Related]
17. Dosing of 3-factor prothrombin complex concentrate for international normalized ratio reversal.
Baggs JH; Patanwala AE; Williams EM; Erstad BL
Ann Pharmacother; 2012 Jan; 46(1):51-6. PubMed ID: 22190253
[TBL] [Abstract][Full Text] [Related]
18. Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.
Holland L; Warkentin TE; Refaai M; Crowther MA; Johnston MA; Sarode R
Transfusion; 2009 Jun; 49(6):1171-7. PubMed ID: 19210325
[TBL] [Abstract][Full Text] [Related]
19. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
20. Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0.
Zemrak WR; Smith KE; Rolfe SS; May T; Trowbridge RL; Hayes TL; Grindlinger GA; Seder DB
Neurocrit Care; 2017 Dec; 27(3):334-340. PubMed ID: 28660341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
